|
K2
|
2
|
Resverlogix Corp.
|
Apr 10, 2021 08:39AM
|
|
Re: Exempt Distribution
|
2
|
Zenith Epigenetics
|
Mar 17, 2020 06:16AM
|
|
Re: Transcript RVX_191031_AGM
|
2
|
Resverlogix Corp.
|
Jan 24, 2020 06:28AM
|
|
Re: K2
|
2
|
Resverlogix Corp.
|
Apr 10, 2021 09:54AM
|
|
Re: PNAS
|
2
|
Resverlogix Corp.
|
Jan 10, 2021 01:15PM
|
|
Re: maybe Zen will go first?
|
2
|
Resverlogix Corp.
|
May 04, 2020 01:48PM
|
|
Zacks
|
2
|
Resverlogix Corp.
|
May 04, 2020 01:50PM
|
|
Saudi
|
2
|
Resverlogix Corp.
|
Jan 15, 2021 11:45AM
|
|
Re: Kool-Aid drinkers be saying just give donny another 2-4 months as we bump off a 100 pennies Canadian after he’s reign of 20 or so years.
|
2
|
Resverlogix Corp.
|
Nov 27, 2020 11:14AM
|
|
Re: K2
|
2
|
Resverlogix Corp.
|
Apr 10, 2021 11:21AM
|
|
Re: Kool-Aid drinkers be saying just give donny another 2-4 months as we bump off a 100 pennies Canadian after he’s reign of 20 or so years.
|
2
|
Resverlogix Corp.
|
Nov 27, 2020 11:25AM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
2
|
Resverlogix Corp.
|
Mar 26, 2020 03:45PM
|
|
Re: Term sheet and enterprise valuation
|
2
|
Zenith Epigenetics
|
Dec 14, 2020 06:32AM
|
|
Financials
|
2
|
Zenith Epigenetics
|
Oct 28, 2020 10:29AM
|
|
Re: K2
|
2
|
Resverlogix Corp.
|
Apr 10, 2021 01:56PM
|
|
Trial
|
2
|
Zenith Epigenetics
|
Nov 21, 2019 12:54PM
|
|
Guess I was wrong
|
2
|
Resverlogix Corp.
|
Dec 05, 2019 08:52AM
|
|
Zenith
|
2
|
Resverlogix Corp.
|
Nov 21, 2019 12:58PM
|
|
Re: Re San fran
|
2
|
Resverlogix Corp.
|
Oct 19, 2020 01:34PM
|
|
Re: maybe Zen will go first?
|
2
|
Resverlogix Corp.
|
May 04, 2020 04:14PM
|
